NYSCC Suppliers’ Day Visit us at Booth 2049 May 19–20 Javits Center, NYC 6 days away

Access Ingredients and Sandream Specialties are now Vivify Beauty Care. All your ingredients, one source.

AccessCARE RET 4.5

4.5% Encapsulated Retinol for Controlled-Release Anti-Aging Performance

INCI Name: Water, Caprylic/Capric Triglyceride, Macadamia Ternifolia Seed Oil, Butylene Glycol, Hydrogenated Lecithin, Polysorbate 20, Retinol, Brassica Campestris (Rapeseed) Sterols, Glycerin, 1,2-Hexanediol, Cholesterol, Ceteth-3, Ceteth-5, Aluminum/Magnesium Hydroxide Stearate, Tocopherol, Potassium Cetyl Phosphate, Disodium EDTA

AccessCARE RET 4.5 is a 4.5% Retinol active built on Vivify’s 3-step encapsulation technology, engineered to protect this notoriously unstable Vitamin A derivative from heat, light, and oxidation while enabling controlled release and enhanced skin penetration. Controlled studies show +60% enhanced skin penetration alongside strong stability retention — 95% Retinol survival after 1 month and 85% after 3 months.

Solubility Notes:

Delivered as a water-based liposomal dispersion; both/dual-soluble due to encapsulation. Add to the water phase; avoid high heat or high-shear processing that could compromise the liposomal structure.

Log In or register to access Safety and Technical Data Sheets and save products as favorites.

Perfect For These Applications

Other cosmetic uses possible—contact us for formulation guidance.

  • Anti-Aging Serums & Treatments
    Core retinol delivery for fine-line and texture claims, leveraging stabilized actives and enhanced penetration.
  • Night Creams & Renewal Treatments
    Controlled-release encapsulation suits overnight use, supporting active integrity away from light/oxidative exposure.
  • Sensitive-Skin Retinol Formulations
    Encapsulation moderates direct retinol exposure, supporting improved tolerability versus unencapsulated retinol.
  • Multi-Active Anti-Aging Systems
    Stabilized retinol pairs with peptides, antioxidants, and other actives without compromising potency.

Performance & Formulation Insights

How It Works: Vitamin A actives like Retinol are highly sensitive to UV, heat, and oxidation, and also present penetration and irritation challenges in raw form. RET 4.5 addresses this with a 3-step encapsulation process: Retinol is first encapsulated within Layered Double Hydroxide (LDH); a second liposome process then forms Multi-Lamellar Vesicles (MLV) that mimic native skin lipid structures; finally, the two encapsulation systems are combined for enhanced protection and delivery.

Formulation Guidelines

Dose based on the 4.5% Retinol concentration of the complex to reach your target finished-product Retinol percentage. Incorporate into the water phase; because the active is pre-encapsulated, avoid excessive heat or high-shear processing. Standard Vitamin A precautions (opaque/airless packaging, antioxidant co-actives) remain good practice even with encapsulation.

Key Formulation Benefits:

  • Enhanced Stability: 95% Retinol survival after 1 month, 85% after 3 months, under controlled conditions.
  • Enhanced Skin Penetration: +60% enhanced skin penetration versus unencapsulated Retinol.
  • Controlled, Skin-Mimetic Delivery: MLV structures mimic native skin lipids for controlled release and improved tolerability.
Heading #1
Benefits
Anti-Aging & Anti-Wrinkle, Antioxidants, Skin Elasticity, Wrinkle Reduction
INCI Name
Water, Caprylic/Capric Triglyceride, Macadamia Ternifolia Seed Oil, Butylene Glycol, Hydrogenated Lecithin, Polysorbate 20, Retinol, Brassica Campestris (Rapeseed) Sterols, Glycerin, 1,2-Hexanediol, Cholesterol, Ceteth-3, Ceteth-5, Aluminum/Magnesium Hydroxide Stearate, Tocopherol, Potassium Cetyl Phosphate, Disodium EDTA
Usage Rate
0.22%-22.22%
Active Type
Vitamin A (Retinoids/Retinol), Vitamins & Derivatives
Solubility
Both/Dual-Soluble
Application Area
Face
Physical Form
Liquid/Solution
Certifications

Frequently Asked Questions About AccessCARE RET 4.5

Via 3-step encapsulation (LDH primary liposome, MLV secondary liposome, combined final encapsulation), yielding 95% Retinol survival after 1 month and 85% after 3 months.
Dose based on the 4.5% Retinol concentration of the complex to hit your target finished-product Retinol percentage.
The controlled-release, skin-mimetic delivery system is designed to support improved tolerability versus unencapsulated retinol, though individual sensitivity testing is still recommended.

Contact An Expert

Only 4 fields to get started. An expert will respond within 1 business day.

AccessCARE RET 4.5